OTC: ACXIF 21.95%
Underperform Recommendation Issued On ACXIF By RBC Capital
NASDAQ: ONMD 72.9%
OneMedNet Stock Soars 90% Following Real-World Data Platform Launch
NASDAQ: PRAA 32.17%
PRA Group (PRAA) Q4 2025 Earnings Call Transcript
NASDAQ: MGN 34.5%
Megan Holdings Limited Announces Closing of $8.3 Million Follow-on Public Offering
NASDAQ: BWIN 28.55%
Baldwin (BWIN) Q4 2025 Earnings Call Transcript
NASDAQ: NGNE 31.15%
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
NASDAQ: ACXIF 72.9%
NASDAQ: PRAA 72.9%
NASDAQ: MGN 72.9%
NASDAQ: BWIN 72.9%
